85 related articles for article (PubMed ID: 573691)
1. Action of posterior pituitary neuropeptides on the nigrostriatal dopaminergic system.
Schulz H; Kovács GL; Telegdy G
Eur J Pharmacol; 1979 Aug; 57(2-3):185-90. PubMed ID: 573691
[TBL] [Abstract][Full Text] [Related]
2. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
[TBL] [Abstract][Full Text] [Related]
3. Oxytocin-conjugated saporin injected into the substantia nigra of male rats alters the activity of the nigrostriatal dopaminergic system: A behavioral and neurochemical study.
Sanna F; Bratzu J; Angioni L; Pina Sorighe M; Cocco C; Argiolas A; Melis MR
Brain Res; 2021 Dec; 1773():147705. PubMed ID: 34744015
[TBL] [Abstract][Full Text] [Related]
4. A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation.
Shapiro RM; Glick SD; Camarota NA
Brain Res; 1987 Nov; 426(2):323-31. PubMed ID: 2446711
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
Robertson GS; Fine A; Robertson HA
Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a role of endogenous opioids in the nigrostriatal system: influence of naloxone and morphine on nigrostriatal dopaminergic supersensitivity.
Hirschhorn ID; Hittner D; Gardner EL; Cubells J; Makman MH
Brain Res; 1983 Jun; 270(1):109-17. PubMed ID: 6409355
[TBL] [Abstract][Full Text] [Related]
7. Effects of paraquat on the substantia nigra of the wistar rats: neurochemical, histological, and behavioral studies.
Liou HH; Chen RC; Tsai YF; Chen WP; Chang YC; Tsai MC
Toxicol Appl Pharmacol; 1996 Mar; 137(1):34-41. PubMed ID: 8607139
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
Giambalvo CT; Snodgrass SR
Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
[TBL] [Abstract][Full Text] [Related]
9. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. I. Unilateral lesions.
Dunnett SB; Björklund A; Stenevi U; Iversen SD
Brain Res; 1981 Jun; 215(1-2):147-61. PubMed ID: 7260584
[TBL] [Abstract][Full Text] [Related]
10. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
[TBL] [Abstract][Full Text] [Related]
11. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. II. Bilateral lesions.
Dunnett SB; Björklund A; Stenevi U; Iversen SD
Brain Res; 1981 Dec; 229(2):457-70. PubMed ID: 6796197
[TBL] [Abstract][Full Text] [Related]
12. Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system.
Javoy F; Sotelo C; Herbet A; Agid Y
Brain Res; 1976 Feb; 102(2):201-15. PubMed ID: 1247882
[TBL] [Abstract][Full Text] [Related]
13. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
Bentlage C; Nikkhah G; Cunningham MG; Björklund A
Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
[TBL] [Abstract][Full Text] [Related]
14. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.
Hudson JL; van Horne CG; Strömberg I; Brock S; Clayton J; Masserano J; Hoffer BJ; Gerhardt GA
Brain Res; 1993 Oct; 626(1-2):167-74. PubMed ID: 8281427
[TBL] [Abstract][Full Text] [Related]
15. Intrastriatal quinolinic acid injections protect against 6-hydroxydopamine-induced lesions of the dopaminergic nigrostriatal system.
Venero JL; Romero-Ramos M; Revuelta M; Machado A; Cano J
Brain Res; 1995 Feb; 672(1-2):153-8. PubMed ID: 7749737
[TBL] [Abstract][Full Text] [Related]
16. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
[TBL] [Abstract][Full Text] [Related]
17. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
Costall B; Naylor RJ; Pycock C
Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
[TBL] [Abstract][Full Text] [Related]
18. Effects of electrolytic and 6-hydroxydopamine lesions of the lateral hypothalamus on rotation evoked by electrical stimulation of the substantia nigra in rats.
Saranak J; Goldfarb J
Brain Res; 1981 Mar; 208(1):81-95. PubMed ID: 7193503
[TBL] [Abstract][Full Text] [Related]
19. Prolactin induces grooming in the rat: possible involvement of nigrostriatal dopaminergic system.
Drago F; Bohus B; Canonico PL; Scapagnini U
Pharmacol Biochem Behav; 1981 Jul; 15(1):61-3. PubMed ID: 7291231
[TBL] [Abstract][Full Text] [Related]
20. Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.
Schwarcz R; Fuxe K; Agnati LF; Hökfelt T; Coyle JT
Brain Res; 1979 Jul; 170(3):485-95. PubMed ID: 37986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
